For Healthcare Professionals Only
Long-term tacrolimus treatment well tolerated in atopic dermatitis
15 August 2008
Tacrolimus is well tolerated and has sustained efficacy when used for up to 4 years in patients with atopic dermatitis, according to the results of a long-term study.
PKC inhibitor AEB071 shows psoriasis treatment potential
The novel protein kinase C inhibitor AEB071 significantly reduces the clinical severity of psoriasis and may be an effective treatment for the condition and other autoimmune diseases, say researchers.
Digital photography effective for patient counseling and education
Digital imaging can be a valuable tool for the dermatologist for patient counseling and follow-up, study findings suggest.
Fractional ablative photothermolysis promising for skin resurfacing
08 August 2008
Fractional ablative photothermolysis using an erbium:YAG laser is a promising option for the treatment of photodamaged facial skin and avoids the side effects associated with ablative laser procedures, study findings indicate.
Smoking and high BMI linked to hidradenitis suppurativa
Hidradenitis suppurativa has a prevalence of 1% and is significantly associated with smoking and being overweight, French study findings suggest.
Once-weekly etanercept efficacy in psoriasis confirmed
An open-label extension study has confirmed the efficacy of once-weekly administration of etanercept 50 mg in patients with moderate-to-severe psoriasis.
Sulfasalazine an option for recalcitrant alopecia areata
01 August 2008
Sulfasalazine can be used as an alternative treatment for alopecia areata in patients who do not respond to standard therapies, study findings suggest.
MAL-PDT cosmetically favorable in small superficial basal cell cancer
Photodynamic therapy with topical methyl aminolevulinate is as effective as simple excision surgery in the treatment of small superficial basal cell carcinoma but offers a more favorable cosmetic outcome, researchers say.
Type I interferons putative psoriasis treatment target
The type I interferon signalling pathway is upregulated in lesional skin of patients with psoriasis, say US researchers.